Full-Time
Clinical Outcomes Specialist
Leap Health
11-50 employees
Transparent infusion benefits for self-funded employers
Compensation Overview
$100k - $135k/yr
Remote in USA
Remote
PharmD
 Biology & Biotech (1) |
|---|
Get referred to Leap Health
See people who can refer or advise you
- At least 3 years of experience in specialty pharmacy, managed care, specialty therapeutics, home infusion, pharmaceutical outcomes, or specialty benefit management is required.
- Direct experience with specialty disease states and specialty medication management is required.
- Demonstrated experience contributing to or owning a clinical outcomes, adherence, quality, or safety measurement effort is required.
- Strong analytical capabilities, including defining metrics, identifying data sources, validating methodologies, and independently developing measurement approaches, are required.
- Experience interpreting and quality-assuring structured clinical data from an electronic health record, care management system, or pharmacy system is required.
- The ability to operate effectively in ambiguous environments and build processes from first principles is required.
- Strong written and verbal communication skills, including the ability to explain methodologies and findings to clinical and non-clinical audiences, are required.
- Build and maintain Leap's outcomes framework across adherence, safety, patient-reported outcomes, and disease-specific clinical measures.
- Define metric definitions, denominator and numerator logic, inclusion criteria, calculation methods, and validity standards.
- Align outcomes methodologies with recognized specialty pharmacy, home infusion, and quality measurement standards where appropriate, including National Home Infusion Association quality measures and other industry benchmarks.
- Maintain clear documentation of metric definitions, methodology updates, and the rationale for changes over time.
- Define and establish Leap's safety event taxonomy and reporting approach across infusion reactions, treatment interruptions, escalation events, near-misses, and other clinically relevant incidents.
- Own the clinical review and quality assurance process supporting accurate safety event capture from clinical documentation and operational workflows.
- Produce recurring safety trend reports for clinical leadership, including root-cause themes, emerging risks, and recommendations for process improvement.
- Build patient-level adherence monitoring across therapies, conditions, and populations.
- Define infusion-specific adherence methodology covering persistence, schedule conformance, dose fidelity, treatment completion, and tolerability.
- Build a risk-flagging process to identify patients at elevated risk for treatment interruption or discontinuation, incorporating missed infusions, delayed authorizations, site-of-care disruptions, and medication access barriers.
- Partner with care teams to operationalize proactive outreach triggers for at-risk patients.
- Select, adapt, and implement validated patient-reported outcome instruments appropriate for specialty infusion populations where clinically appropriate.
- Partner with Engineering and Clinical Operations to implement survey delivery workflows and structured response capture.
- Analyze and interpret outcomes data to generate clinically defensible evidence of program impact.
- Produce outcomes reporting and evidence packages supporting employer reporting, client quarterly business reviews, payer discussions, and manufacturer partnerships.
- A PharmD, Master of Public Health, Registered Nurse credential, or other relevant clinical or population health training is preferred.
- Experience in home infusion or alternate site-of-care models is preferred.
- Familiarity with specialty pharmacy and infusion quality benchmarks, including National Home Infusion Association, URAC, and related quality frameworks is preferred.
- Experience implementing or analyzing validated patient-reported outcome measures is preferred.
- Population health analytics or healthcare outcomes experience is preferred.
- Experience supporting payer, employer, or pharmaceutical manufacturer reporting is preferred.
- Familiarity with healthcare analytics and reporting tools is preferred.
- Working knowledge of biostatistical principles relevant to healthcare outcomes measurement is preferred.
Leap Health coordinates transparent, pass-through specialty infusion benefits for self-funded employers, reducing drug costs by up to 60%. The service pairs employees with licensed Care Guides (nurses and pharmacists) to manage the entire infusion process, including prior authorizations and care navigation, with options for home infusion or infusion centers. It avoids opaque drug markups and operates on a fee-for-service model without per-member-per-month or fixed admin fees, aiming to deliver a quick return on investment for clients from the first patient treated. Leap focuses on patient-centered care, simplifying access to infusion therapy and coordinating care through consultants, brokers, and TPAs across all 50 states, with growing coverage and a high NPS score (92). The company’s goal is to reduce specialty drug costs, improve access and convenience for employees, and provide transparent, value-based health benefits to self-funded employers.
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2023
Get referred to Leap Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Leap reported 25x year-over-year covered-life growth on February 4, 2026.
- Leap raised $4 million seed financing in March 2024, funding expansion.
- Alight added Leap to its Partner Network in 2026, validating enterprise demand.
What critics are saying
- Big PBMs and national health platforms can bundle infusion into broader contracts by 2027.
- Leap still depends on employer adoption; one delayed sales cycle crushes 2026 growth.
- Specialty infusion margins invite insurer replication, turning Leap into a replaceable middle layer.
What makes Leap Health unique
- Leap’s pass-through infusion pricing eliminates provider markups across self-funded employer plans.
- Leap coordinates home and nearby-center infusions with licensed Care Guides across 50 states.
- Leap’s 2026 Alight, Angle Health, Amwins, and Castlight integrations widen distribution.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -2%2 year growth
↓ -2%Alight adds Cylinder and Leap to Partner Network. Jenna Jordan Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth, leave and point solutions, today announced the expansion of its Alight Partner Network with the addition of Cylinder Health and Leap, two partners that strengthen Alight's ability to help employers deliver high-impact health solutions. The Alight Partner Network offers a curated ecosystem of solutions designed to help employers deliver a more connected and engaging employee experience. With the addition of Cylinder and Leap, Alight enables clients to access trusted specialty solutions through their existing Alight relationship. "By welcoming Cylinder and Leap to the Alight Partner Network, we are enhancing our ability to deliver innovative, high-impact health solutions that address the evolving needs of our clients and their employees," said Jessica Borchik, SVP, Partner Strategy and Sales at Alight. "These partnerships reinforce our commitment to providing employers with access to trusted specialty solutions through a single, connected experience, helping organizations support the health and wellbeing of their workforce while managing costs effectively." Digestive health care with Cylinder Cylinder helps employers and health plans reduce avoidable digestive health costs by connecting employees to earlier, coordinated care. It delivers integrated virtual-first digestive health support across gastrointestinal (GI) conditions, nutrition and behavioral health, helping employees access personalized digestive care sooner while supporting better health outcomes and a more seamless care experience. Cylinder has demonstrated strong engagement and meaningful symptom improvement across employers and health plan populations, while helping members access earlier digestive health support before symptoms escalate into higher-cost care. In addition, Cylinder helps employees access the right digestive care faster by: * Accelerating access to personalized care. Structured digital intake and real-time symptom tracking support triage and enable individualized care from the start. * Supporting whole-person digestive health. An integrated virtual care team spanning gastroenterology, nutrition and gut-brain health delivers coordinated support across digestive health needs. * Maintaining continuity across the care journey. Coordinated referrals and provider communication help ensure a connected experience extends beyond visits. "GI conditions are among the largest and most overlooked cost drivers for employers, yet many employees still struggle to access timely, coordinated digestive health support," said Ryan Sloan, Chief Commercial Officer at Cylinder. "By working with Alight, we can help employers close critical gaps in digestive care access, connect employees to support earlier, and reduce avoidable utilization while improving the overall care experience." Infusion therapy with Leap Leap is a leading infusion therapy partner for self-funded employers, delivering high-quality specialty infusion care in the home and at convenience nearby infusion centers. By coordinating care, managing complex treatments, navigating benefits and transparent drug pricing with no markup, Leap improves the experience for patients while lowering total cost of care for employers. The result is more convenient care and improved adherence for employees with serious or chronic conditions and stronger clinical and financial outcomes for employers. "Specialty infusion has become one of the fastest-growing drivers of self-funded employer healthcare spend, while patients often pay the price in delayed treatment, unnecessary travel and fragmented care," said Rob LaHayne, Cofounder and Chief Commercial Officer, Leap. "By joining the Alight Partner Network, Leap brings greater transparency and convenience to infusion therapy, helping employers reduce costs while ensuring employees receive timely, convenient, coordinated care." The Alight Partner Network helps extend the breadth of employers' offerings for organizations to thrive and provide benefits that support health, wealth and leave. To learn more about Alight's Partner Network, visit alight.com. About Cylinder Cylinder is a virtual-first digestive health solution delivering personalized, clinician-backed care for the full spectrum of gastrointestinal (GI) conditions and symptoms, including GERD, ulcerative colitis, celiac disease, bloating, constipation, and more. With a dedicated care team that includes GI doctors, registered dietitians, and health coaches, Cylinder has supported more than 150,000 patients across all 50 states. Backed by published, peer-reviewed clinical results, Cylinder has demonstrated strong engagement, meaningful symptom improvement, and strong ROI for employer populations. Cylinder works with employers and health plans to improve access to digestive care, reduce avoidable utilization, and deliver a more connected care experience. Learn more at Cylinder Health. About Leap Leap is the leading transparent infusion benefit solution for self-funded employers. Leap eliminates hidden provider markups on specialty drugs and coordinates infusion care end-to-end, while delivering a personalized patient experience that earns a strong Net Promoter Score (NPS). Learn more at leaphealth.com and follow us on LinkedIn. Media contacts.
Leap partners with Angle Health to simplify and transform infusion care. Leap has partnered with Angle Health to make infusion care simpler, more transparent, and less disruptive for employers and the employees who rely on infusion therapy. Infusion is one of the fastest-growing cost categories in employer healthcare. Too often, the experience is opaque: unclear pricing, multiple vendors, and treatment that requires time away from work and home. This partnership brings a more connected experience, combining Angle's benefits platform with Leap's infusion expertise and coordination, so members can get to the right setting of care and employers have clearer visibility into what they're paying for. "We're able to proactively guide members to the right treatment setting, deliver a dramatically better care experience, and reduce costs for employers - all within a unified, easy-to-navigate benefits experience rather than a patchwork of disconnected vendors." - Rob LaHayne, Co-Founder, Leap Health. A big part of the opportunity is site of care. Many infusions still happen in hospitals or infusion centers, even when home infusion may be clinically appropriate. When care is delivered closer to home and with the right clinical support, it reduces disruption for members and helps employers manage cost more effectively. Read the full announcement here: What this partnership means * A more seamless experience: benefits and specialty infusion support that feels connected, not stitched together. * More cost transparency: Leap's pass-through approach helps eliminate hidden markups and gives employers clearer visibility. * Support finding the right setting of care: including at-home infusion when clinically appropriate, to reduce disruption and avoid unnecessary high-cost settings. * Better coordination for members: fewer handoffs, less confusion, and a smoother path from benefits to care delivery. "Partnering with Leap Health extends that mission into infusion care delivery. When people understand their options and are supported every step of the way, everyone wins." - Ty Wang, Co-Founder & CEO, Angle Health If you are a self-funded employer or broker and infusion spend is on your radar, contact Leap to see how Leap Health, Inc. can help. This post summarizes an announcement originally distributed via Business Wire. Read the full release here. More insights. News 02/04/2026 Leap posts 25x growth; expands executive team. NEW YORK, NY - February 4, 2026 - Leap, the leading infusion therapy partner for self-funded employe... Education 01/20/2026 Why specialty infusion costs are straining employer healthcare budgets. Specialty infusion costs are quietly becoming one of the most significant pressures on employer heal... Education 01/03/2026 The infusion cost crisis: why medical benefit drug spend keeps escalating. For employers, however, infusion care has quietly become one of the fastest-growing and least unders... News 12/02/2025 Leap joins the Castlight ecosystem to simplify infusion care. Leap has joined the Castlight ecosystem to give TPAs and employers a more transparent, predictable,... Insights 11/30/2025 Rebates, what rebates? Understanding pharmacy rebates for j-code drugs. Pharmacy rebates are manufacturer-paid discounts, typically negotiated behind Education 11/30/2025 Demystifying specialty drug pricing acronyms, and why they all fail employers. Behind the exorbitant costs of infusion therapies, you'll find layers of complexity - and three acrony... Clinical 11/27/2025 Safely infusing Immunoglobulin in the home setting: clinical considerations and best practices. Immunoglobulin (Ig) therapies are essential in the treatment of primary immunodeficiency (PID), chro... News 10/17/2025 Leap and Amwins partner to deliver low-cost, convenient infusion therapy. Leap and Amwins Rx, today announced a strategic collaboration that will bring significant benefits t... Case Study 07/29/2025 Bringing relief home for annie. Helping a working parent stay on track with infusion care Insights 07/27/2025 How Leap reduces the total cost of multiple sclerosis care. For patients requiring long-term MS infusions like Ocrevus or Tysabri, traditional hospital-based tr...